Published in J Bacteriol on June 01, 2000
sigmaB modulates virulence determinant expression and stress resistance: characterization of a functional rsbU strain derived from Staphylococcus aureus 8325-4. J Bacteriol (2002) 6.71
RNAIII-independent target gene control by the agr quorum-sensing system: insight into the evolution of virulence regulation in Staphylococcus aureus. Mol Cell (2008) 3.44
Global regulation of Staphylococcus aureus genes by Rot. J Bacteriol (2003) 3.02
agr function in clinical Staphylococcus aureus isolates. Microbiology (2008) 2.33
Mgr, a novel global regulator in Staphylococcus aureus. J Bacteriol (2003) 2.14
Increased expression of clumping factor and fibronectin-binding proteins by hemB mutants of Staphylococcus aureus expressing small colony variant phenotypes. Infect Immun (2002) 2.08
SarS, a SarA homolog repressible by agr, is an activator of protein A synthesis in Staphylococcus aureus. Infect Immun (2001) 2.02
Staphylococcus aureus CcpA affects virulence determinant production and antibiotic resistance. Antimicrob Agents Chemother (2006) 1.99
Effect of mild acid on gene expression in Staphylococcus aureus. J Bacteriol (2004) 1.96
SarT, a repressor of alpha-hemolysin in Staphylococcus aureus. Infect Immun (2001) 1.89
Peptide signaling in the staphylococci. Chem Rev (2010) 1.89
Quorum sensing in Staphylococcus infections. J Clin Invest (2003) 1.79
Global regulation of gene expression by ArlRS, a two-component signal transduction regulatory system of Staphylococcus aureus. J Bacteriol (2005) 1.72
Molecular architecture of the regulatory Locus sae of Staphylococcus aureus and its impact on expression of virulence factors. J Bacteriol (2003) 1.67
Staphylococcus aureus leucocidin ED contributes to systemic infection by targeting neutrophils and promoting bacterial growth in vivo. Mol Microbiol (2011) 1.64
Inactivation of a two-component signal transduction system, SaeRS, eliminates adherence and attenuates virulence of Staphylococcus aureus. Infect Immun (2006) 1.63
Identification of sarV (SA2062), a new transcriptional regulator, is repressed by SarA and MgrA (SA0641) and involved in the regulation of autolysis in Staphylococcus aureus. J Bacteriol (2004) 1.52
MsrR, a putative cell envelope-associated element involved in Staphylococcus aureus sarA attenuation. Antimicrob Agents Chemother (2003) 1.52
sarU, a sarA homolog, is repressed by SarT and regulates virulence genes in Staphylococcus aureus. Infect Immun (2003) 1.48
Genome analysis of the meat starter culture bacterium Staphylococcus carnosus TM300. Appl Environ Microbiol (2008) 1.38
TcaR, a putative MarR-like regulator of sarS expression. J Bacteriol (2004) 1.36
Regulation of hemolysin expression and virulence of Staphylococcus aureus by a serine/threonine kinase and phosphatase. PLoS One (2010) 1.34
Genome sequence survey identifies unique sequences and key virulence genes with unusual rates of amino Acid substitution in bovine Staphylococcus aureus. Infect Immun (2002) 1.33
The bicomponent pore-forming leucocidins of Staphylococcus aureus. Microbiol Mol Biol Rev (2014) 1.32
Global virulence regulation in Staphylococcus aureus: pinpointing the roles of ClpP and ClpX in the sar/agr regulatory network. Infect Immun (2005) 1.27
Regulatory elements of the Staphylococcus aureus protein A (Spa) promoter. J Bacteriol (2004) 1.25
Predicting the virulence of MRSA from its genome sequence. Genome Res (2014) 1.23
The Genomic Aspect of Virulence, Sepsis, and Resistance to Killing Mechanisms in Staphylococcus aureus. Curr Infect Dis Rep (2002) 1.22
Identification and characterization of sigma, a novel component of the Staphylococcus aureus stress and virulence responses. PLoS One (2008) 1.19
SarA is a repressor of hla (alpha-hemolysin) transcription in Staphylococcus aureus: its apparent role as an activator of hla in the prototype strain NCTC 8325 depends on reduced expression of sarS. J Bacteriol (2006) 1.16
Modulation of fibronectin adhesins and other virulence factors in a teicoplanin-resistant derivative of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2004) 1.16
Repression of hla by rot is dependent on sae in Staphylococcus aureus. Infect Immun (2008) 1.14
Expression of SarX, a negative regulator of agr and exoprotein synthesis, is activated by MgrA in Staphylococcus aureus. J Bacteriol (2006) 1.14
NsaRS is a cell-envelope-stress-sensing two-component system of Staphylococcus aureus. Microbiology (2011) 1.13
Beta-lactams interfering with PBP1 induce Panton-Valentine leukocidin expression by triggering sarA and rot global regulators of Staphylococcus aureus. Antimicrob Agents Chemother (2011) 1.12
Staphylococcus aureus isolated in cases of impetigo produces both epidermolysin A or B and LukE-LukD in 78% of 131 retrospective and prospective cases. J Clin Microbiol (2001) 1.07
Rot and SaeRS cooperate to activate expression of the staphylococcal superantigen-like exoproteins. J Bacteriol (2012) 1.06
Induction of fibronectin adhesins in quinolone-resistant Staphylococcus aureus by subinhibitory levels of ciprofloxacin or by sigma B transcription factor activity is mediated by two separate pathways. Antimicrob Agents Chemother (2005) 1.03
Role of the distal sarA promoters in SarA expression in Staphylococcus aureus. Infect Immun (2005) 1.02
Evolution of hypervirulence by a MRSA clone through acquisition of a transposable element. Mol Microbiol (2014) 1.01
Staphylococcus aureus regulates the expression and production of the staphylococcal superantigen-like secreted proteins in a Rot-dependent manner. Mol Microbiol (2011) 0.99
Expression of the sarA family of genes in different strains of Staphylococcus aureus. Microbiology (2009) 0.98
sarZ, a sarA family gene, is transcriptionally activated by MgrA and is involved in the regulation of genes encoding exoproteins in Staphylococcus aureus. J Bacteriol (2008) 0.97
Accessory gene regulator control of staphyloccoccal enterotoxin d gene expression. J Bacteriol (2004) 0.96
The chaperone ClpX stimulates expression of Staphylococcus aureus protein A by Rot dependent and independent pathways. PLoS One (2010) 0.95
A rot mutation restores parental virulence to an agr-null Staphylococcus aureus strain in a rabbit model of endocarditis. Infect Immun (2005) 0.94
Regulation of superoxide dismutase (sod) genes by SarA in Staphylococcus aureus. J Bacteriol (2009) 0.94
Control of thioredoxin reductase gene (trxB) transcription by SarA in Staphylococcus aureus. J Bacteriol (2010) 0.93
RpiR homologues may link Staphylococcus aureus RNAIII synthesis and pentose phosphate pathway regulation. J Bacteriol (2011) 0.92
The extracytoplasmic function sigma factor σS protects against both intracellular and extracytoplasmic stresses in Staphylococcus aureus. J Bacteriol (2012) 0.91
Identification of the Staphylococcus aureus vfrAB operon, a novel virulence factor regulatory locus. Infect Immun (2014) 0.91
Rot repression of enterotoxin B expression in Staphylococcus aureus. J Bacteriol (2005) 0.90
Silkworm apolipophorin protein inhibits Staphylococcus aureus virulence. J Biol Chem (2011) 0.89
Fate of mutation rate depends on agr locus expression during oxacillin-mediated heterogeneous-homogeneous selection in methicillin-resistant Staphylococcus aureus clinical strains. Antimicrob Agents Chemother (2011) 0.88
Rot is a key regulator of Staphylococcus aureus biofilm formation. Mol Microbiol (2015) 0.87
Regulation of Rot expression in Staphylococcus aureus. J Bacteriol (2007) 0.87
Phage P68 virion-associated protein 17 displays activity against clinical isolates of Staphylococcus aureus. Antimicrob Agents Chemother (2005) 0.86
Facing antibiotic resistance: Staphylococcus aureus phages as a medical tool. Viruses (2014) 0.85
The production of extracellular proteins is regulated by ribonuclease III via two different pathways in Staphylococcus aureus. PLoS One (2011) 0.81
Identification of single nucleotide polymorphisms associated with hyperproduction of alpha-toxin in Staphylococcus aureus. PLoS One (2011) 0.81
Impact of the Regulators SigB, Rot, SarA and sarS on the Toxic Shock Tst Promoter and TSST-1 Expression in Staphylococcus aureus. PLoS One (2015) 0.81
Quorum-sensing regulation in staphylococci-an overview. Front Microbiol (2015) 0.81
Insights on virulence from the complete genome of Staphylococcus capitis. Front Microbiol (2015) 0.78
Positive Regulation of Staphylococcal Enterotoxin H by Rot (Repressor of Toxin) Protein and Its Importance in Clonal Complex 81 Subtype 1 Lineage-Related Food Poisoning. Appl Environ Microbiol (2015) 0.78
Rot and Agr system modulate fibrinogen-binding ability mainly by regulating clfB expression in Staphylococcus aureus NCTC8325. Med Microbiol Immunol (2011) 0.78
Regulation of Staphylococcal Superantigen-Like Gene, ssl8, Expression in Staphylococcus aureus strain, RN6390. Clin Med Res (2014) 0.78
Characterization of a novel two-component regulatory system, HptRS, the regulator for the hexose phosphate transport system in Staphylococcus aureus. Infect Immun (2015) 0.78
Structure-based functional characterization of repressor of toxin (Rot), a central regulator of Staphylococcus aureus virulence. J Bacteriol (2014) 0.77
A spectrum of CodY activities drives metabolic reorganization and virulence gene expression in Staphylococcus aureus. Mol Microbiol (2016) 0.75
The novel transcriptional regulator SA1804 Is involved in mediating the invasion and cytotoxicity of Staphylococcus aureus. Front Microbiol (2015) 0.75
VfrB is a key activator of the Staphylococcus aureus SaeRS two-component system. J Bacteriol (2016) 0.75
The SaeRS Two-Component System of Staphylococcus aureus. Genes (Basel) (2016) 0.75
Exploration of Modulated Genetic Circuits Governing Virulence Determinants in Staphylococcus aureus. Indian J Microbiol (2015) 0.75
Synthesis of staphylococcal virulence factors is controlled by a regulatory RNA molecule. EMBO J (1993) 11.30
Cloning, characterization, and sequencing of an accessory gene regulator (agr) in Staphylococcus aureus. J Bacteriol (1988) 8.18
Bacterial interference caused by autoinducing peptide variants. Science (1997) 7.96
Distribution of haemolysins in pathogenic and non-pathogenic staphylococci. J Pathol Bacteriol (1950) 7.13
Regulation of exoprotein expression in Staphylococcus aureus by a locus (sar) distinct from agr. Proc Natl Acad Sci U S A (1992) 6.95
Cell density control of staphylococcal virulence mediated by an octapeptide pheromone. Proc Natl Acad Sci U S A (1995) 6.13
Antimicrobial resistance of Staphylococcus aureus: genetic basis. Microbiol Rev (1987) 6.00
The role of the delta-lysin gene (hld) in the regulation of virulence genes by the accessory gene regulator (agr) in Staphylococcus aureus. EMBO J (1990) 5.55
The agr P2 operon: an autocatalytic sensory transduction system in Staphylococcus aureus. Mol Gen Genet (1995) 4.63
A temporal signal, independent of agr, is required for hla but not spa transcription in Staphylococcus aureus. J Bacteriol (1991) 4.23
Deletion of the alternative sigma factor sigmaB in Staphylococcus aureus reveals its function as a global regulator of virulence genes. J Bacteriol (1998) 4.18
The small RNA, DsrA, is essential for the low temperature expression of RpoS during exponential growth in Escherichia coli. EMBO J (1996) 4.10
Activation of alpha-toxin translation in Staphylococcus aureus by the trans-encoded antisense RNA, RNAIII. EMBO J (1995) 3.64
Sigma-B, a putative operon encoding alternate sigma factor of Staphylococcus aureus RNA polymerase: molecular cloning and DNA sequencing. J Bacteriol (1996) 3.58
Cloning and sequencing of sarA of Staphylococcus aureus, a gene required for the expression of agr. J Bacteriol (1994) 3.54
The molecular architecture of the sar locus in Staphylococcus aureus. J Bacteriol (1996) 3.46
Riboregulation in Escherichia coli: DsrA RNA acts by RNA:RNA interactions at multiple loci. Proc Natl Acad Sci U S A (1998) 3.45
SarA, a global regulator of virulence determinants in Staphylococcus aureus, binds to a conserved motif essential for sar-dependent gene regulation. J Biol Chem (1999) 3.11
Characterization of the sar locus and its interaction with agr in Staphylococcus aureus. J Bacteriol (1996) 3.05
Phenotypic characterization of xpr, a global regulator of extracellular virulence factors in Staphylococcus aureus. Infect Immun (1993) 3.05
Rapid isolation of DNA from Staphylococcus aureus. Appl Environ Microbiol (1983) 3.03
The Staphylococcus aureus alternative sigma factor sigmaB controls the environmental stress response but not starvation survival or pathogenicity in a mouse abscess model. J Bacteriol (1998) 2.99
Transmembrane topology and histidine protein kinase activity of AgrC, the agr signal receptor in Staphylococcus aureus. Mol Microbiol (1998) 2.77
Glucose and nonmaintained pH decrease expression of the accessory gene regulator (agr) in Staphylococcus aureus. Infect Immun (1992) 2.70
Transcriptional control of the agr-dependent virulence gene regulator, RNAIII, in Staphylococcus aureus. Mol Microbiol (1996) 2.69
Regulation of protein A synthesis by the sar and agr loci of Staphylococcus aureus. Infect Immun (1997) 2.30
Role of host factors in the regulation of the enterotoxin B gene. J Bacteriol (1991) 1.72
Insertional inactivation of a chromosomal locus that modulates expression of potential virulence determinants in Staphylococcus aureus. J Bacteriol (1995) 1.47
Genetic instability of the global regulator agr explains the phenotype of the xpr mutation in Staphylococcus aureus KSI9051. J Bacteriol (1998) 1.42
Impact of changing pathogens and antimicrobial susceptibility patterns in the treatment of serious infections in hospitalized patients. Am J Med (1996) 1.37
Involvement of the accessory gene regulator (agr) in expression of type 5 capsular polysaccharide by Staphylococcus aureus. J Gen Microbiol (1993) 1.33
Translation of RNAIII, the Staphylococcus aureus agr regulatory RNA molecule, can be activated by a 3'-end deletion. FEMS Microbiol Lett (1995) 1.30
Molecular evolution of multiply-antibiotic-resistant staphylococci. Ciba Found Symp (1997) 1.07
Binding and factor XIIIa-mediated cross-linking of a 27-kilodalton fragment of fibronectin to Staphylococcus aureus. Science (1980) 3.68
Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis. J Infect Dis (1998) 3.61
A site-directed Staphylococcus aureus hemB mutant is a small-colony variant which persists intracellularly. J Bacteriol (1997) 3.25
Gentamicin-resistant menadione and hemin auxotrophic Staphylococcus aureus persist within cultured endothelial cells. J Infect Dis (1994) 2.91
Recovery of small colony variants of Staphylococcus aureus following gentamicin bead placement for osteomyelitis. Clin Infect Dis (1997) 2.82
Fibronectin binding to Staphylococcus aureus. J Biol Chem (1982) 2.54
Reduced adherence to traumatized rat heart valves by a low-fibronectin-binding mutant of Staphylococcus aureus. Infect Immun (1989) 2.36
Fibronectin mediates attachment of Staphylococcus aureus to human neutrophils. Blood (1982) 1.93
Phagocytosis of Staphylococcus aureus by cultured bovine aortic endothelial cells: model for postadherence events in endovascular infections. Infect Immun (1986) 1.93
Use of adhesion-defective mutants of Staphylococcus aureus to define the role of specific plasma proteins in promoting bacterial adhesion to canine arteriovenous shunts. Infect Immun (1995) 1.85
Staphylocidal action of thrombin-induced platelet microbicidal protein is not solely dependent on transmembrane potential. Infect Immun (1996) 1.79
Ingestion of Staphylococcus aureus by bovine endothelial cells results in time- and inoculum-dependent damage to endothelial cell monolayers. Infect Immun (1987) 1.55
Cytotoxic effects of ingested Staphylococcus aureus on bovine endothelial cells: role of S. aureus alpha-hemolysin. Microb Pathog (1988) 1.46
Phagocytosis of Francisella tularensis by Rhesus monkey peripheral leukocytes. Infect Immun (1975) 1.46
Fibronectin-induced agglutination of Staphylococcus aureus correlates with invasiveness. J Lab Clin Med (1984) 1.46
Decreased susceptibility to antibiotic killing of a stable small colony variant of Staphylococcus aureus in fluid phase and on fibronectin-coated surfaces. J Antimicrob Chemother (1997) 1.44
Staphylococcus aureus small colony variants are induced by the endothelial cell intracellular milieu. J Infect Dis (1996) 1.43
Protection of mice against lethal endotoxemia by a lipid A precursor. Infect Immun (1986) 1.42
Bloodstream infections caused by small-colony variants of coagulase-negative staphylococci following pacemaker implantation. Clin Infect Dis (1999) 1.39
Coagulase-negative staphylococci. Pathogens have major role in nosocomial infections. Postgrad Med (2001) 1.38
Cutting edge: the nucleotide receptor P2X7 contains multiple protein- and lipid-interaction motifs including a potential binding site for bacterial lipopolysaccharide. J Immunol (2001) 1.37
Fibronectin is more active than fibrin or fibrinogen in promoting Staphylococcus aureus adherence to inserted intravascular catheters. J Infect Dis (1993) 1.34
Adhesion of Staphylococcus aureus to surface-bound platelets: role of fibrinogen/fibrin and platelet integrins. J Infect Dis (1993) 1.34
Endotoxin in vitro interactions with human neutrophils: depression of chemiluminescence, oxygen consumption, superoxide production, and killing. Infect Immun (1979) 1.32
Elicitation of peritoneal polymorphonuclear neutrophils from mice. J Immunol Methods (1982) 1.32
Staphylococcus aureus small colony variants, electron transport and persistent infections. Int J Antimicrob Agents (2000) 1.31
Where does a Staphylococcus aureus vaccine stand? Clin Microbiol Infect (2014) 1.18
Purinergic receptor modulation of lipopolysaccharide signaling and inducible nitric-oxide synthase expression in RAW 264.7 macrophages. J Biol Chem (1998) 1.17
Biological and clinical effects of intravenous tumor necrosis factor-alpha administered three times weekly. Cancer Res (1991) 1.16
Effects of subinhibitory concentrations of antibiotics on Staphylococcus aureus interactions with fibronectin. J Antimicrob Chemother (1983) 1.16
Regulation of inducible nitric oxide synthase expression by macrophage purinoreceptors and calcium. J Biol Chem (1996) 1.12
Lipid X ameliorates pulmonary hypertension and protects sheep from death due to endotoxin. Infect Immun (1987) 1.09
Blastomycosis is a serious disease, but let's not raise fears without conclusive data. WMJ (2001) 1.07
Quantitative comparison of clumping factor- and coagulase-mediated Staphylococcus aureus adhesion to surface-bound fibrinogen under flow. Infect Immun (1995) 1.06
Role of host and bacterial factors in modulating staphylococcal adhesion to implanted polymer surfaces. J Biomater Appl (1990) 1.05
Role of fibronectin in human monocyte and macrophage bactericidal activity. Infect Immun (1985) 1.05
Toward an understanding of biomaterial infections: a complex interplay between the host and bacteria. J Lab Clin Med (2000) 1.04
Subinhibitory concentrations of antibiotics alter fibronectin binding to Staphylococcus aureus. Antimicrob Agents Chemother (1983) 1.04
Immunoelectron microscopic localization of fibronectin in adherence of Staphylococcus aureus to cultured bovine endothelial cells. J Infect Dis (1989) 1.03
Aedes aegypti: induced antibacterial proteins reduce the establishment and development of Brugia malayi. Exp Parasitol (1996) 1.02
Host defences and the vaginal mucosa. A re-evaluation. Scand J Urol Nephrol Suppl (1984) 1.00
Activation and inhibition of Limulus amebocyte lysate coagulation by chemically defined substructures of lipid A. Infect Immun (1985) 1.00
FT-IR microspectroscopic imaging of flax (Linum usitatissimum L.) stems. Cell Mol Biol (Noisy-le-grand) (1998) 1.00
Left ventricular assist device infection is associated with increased mortality but is not a contraindication to transplantation. Circulation (1997) 0.97
Genetic differences in oxygen toxicity are correlated with cytochrome P-450 inducibility. Proc Natl Acad Sci U S A (1985) 0.96
Immunostimulatory, but not antiendotoxin, activity of lipid X is due to small amounts of contaminating N,O-acylated disaccharide-1-phosphate: in vitro and in vivo reevaluation of the biological activity of synthetic lipid X. Infect Immun (1991) 0.95
Lipid X protects mice against fatal Escherichia coli infection. Infect Immun (1988) 0.95
Bacterial colonization of functionalized polyurethanes. Biomaterials (2000) 0.94
Novel animal model for studying the molecular mechanisms of bacterial adhesion to bone-implanted metallic devices: role of fibronectin in Staphylococcus aureus adhesion. J Orthop Res (1996) 0.92
A low-fibronectin-binding mutant of Staphylococcus aureus 879R4S has Tn918 inserted into its single fnb gene. Microbiology (1996) 0.91
Pulmonary pathophysiological changes in sheep caused by endotoxin precursor, lipid X. J Appl Physiol (1985) (1985) 0.90
Staphylococcus aureus small colony variants: formation and clinical impact. Int J Clin Pract Suppl (2000) 0.89
Haemophilus parainfluenzae vertebral osteomyelitis. Am J Med Sci (1987) 0.87
In vitro study of antiviral activity of immune spleen cells in experimental Venezuelan equine encephalomyelitis infection in mice. J Immunol (1974) 0.86
Comparative study of lipopolysaccharide-, lipid IVa-, and lipid X-induced tumor necrosis factor production in murine macrophage-like cell lines. Adv Exp Med Biol (1990) 0.86
Gender similarity in low agreement between written and video ISAAC asthma questionnaires. Monaldi Arch Chest Dis (2006) 0.84
Recombinant interferon-gamma preserves human granulocyte bactericidal and chemoluminescence activities. J Infect Dis (1993) 0.83
Quantitative comparison of shear-dependent Staphylococcus aureus adhesion to three polyurethane ionomer analogs with distinct surface properties. J Biomed Mater Res (1997) 0.83
Pharmacodynamic evaluation of the activity of antibiotics against hemin- and menadione-dependent small-colony variants of Staphylococcus aureus in models of extracellular (broth) and intracellular (THP-1 monocytes) infections. Antimicrob Agents Chemother (2012) 0.83
Small colony variants of Staphylococci: a link to persistent infections. Berl Munch Tierarztl Wochenschr (2000) 0.82
Simple procedure for measuring neutrophil chemiluminescence. J Clin Microbiol (1981) 0.82
Effect of dose and method of administration of endotoxin on cell mediator release in neonatal calves. Am J Vet Res (1993) 0.82
Bacterial lipopolysaccharide-stimulated GTPase activity in RAW 264.7 macrophage membranes. Biochem J (1991) 0.81
Inefficient in vitro killing of virulent or nonvirulent Salmonella typhimurium by murine polymorphonuclear neutrophils. Can J Microbiol (1984) 0.81
Clinical and biologic effects of combination therapy with gamma-interferon and tumor necrosis factor. Cancer (1992) 0.81
Elimination and tissue distribution of the monosaccharide lipid A precursor, lipid X, in mice and sheep. Antimicrob Agents Chemother (1988) 0.80
Normalization of intracellular calcium: a sweet solution to neutrophil dysfunction in diabetes? Ann Intern Med (1995) 0.80
High levels of HCV core+1 antibodies in HCV patients with hepatocellular carcinoma. J Gen Virol (2011) 0.79
Bacterial adhesion to functionalized polyurethanes. J Biomater Sci Polym Ed (1999) 0.79
Pulmonary pressor responses in sheep to chemically defined precursors of E. coli endotoxin. J Appl Physiol (1985) (1987) 0.79
Salicylate-induced enzymuria: comparison with other anti-inflammatory agents. Am J Med (1978) 0.78
Nuclear translocation of NF-kappaB in lipopolysaccharide-treated macrophages fails to correspond to endotoxicity: evidence suggesting a requirement for a gamma interferon-like signal. Infect Immun (1998) 0.78
[Development of gentamicin-resistant Small Colony Variants of S. aureus after implantation of gentamicin chains in osteomyelitis as a possible cause of recurrence]. Z Orthop Ihre Grenzgeb (1998) 0.78
Bacterial sepsis in patients with acquired immunodeficiency syndrome. Crit Care Med (2001) 0.78
Alterations in clinical, hematological and metabolic variables in bovine neonatal endotoxemia. Can J Vet Res (1995) 0.78
Perfluorodecalin and bone regeneration. Eur Cell Mater (2013) 0.77
Paradoxical neutrophil activation and coagulopathy during the recovery phase after endotoxemia. Crit Care Med (2001) 0.75
Potential risk factors for developing apoptosis during septic shock. Crit Care Med (2000) 0.75
New drugs for the treatment of septic shock. Crit Care Med (2001) 0.75
Cilastatin does not alter superoxide dismutase activity. Antimicrob Agents Chemother (1985) 0.75
A Lack of tolerance to the anxiolytic action of Echium amoenum. Res Pharm Sci (2011) 0.75
Effect of Staphylococcus aureus enterotoxin F on human neutrophil oxidative metabolism. J Infect Dis (1983) 0.75
Lipopolysaccharide-induced priming of the murine macrophage-like cell line J774A.1 for enhanced production of reactive oxygen intermediates is blocked by antiserum to murine interferon beta. Adv Exp Med Biol (1990) 0.75
Effect of chelating agents and superoxide on human neutrophil NAD(P)H oxidation. Anal Biochem (1984) 0.75
Oxidative metabolism of circulating neutrophils in infantile (Philadelphia chromosome-negative) chronic myelogenous leukemia. Pediatr Hematol Oncol (1986) 0.75
Infectious diseases in Wisconsin. WMJ (1998) 0.75
Lipopolysaccharide, but not lethal infection, releases tumor necrosis factor in mice. Adv Exp Med Biol (1990) 0.75
University of California/Davis Interdepartmental Conference on gram-negative septicemia. Rev Infect Dis (1991) 0.75
Renal vein thrombosis distal to patent splenorenal shunt. JAMA (1971) 0.75
The pathogenesis of S. aureus endocarditis. J Lab Clin Med (1989) 0.75